Scinai Immunotherapeutics Ltd.

Healthcare · Biotechnology · Israel

Last price 0.4716 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 268.82K

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis. The company also offers contract development and manufacturing organization services, such as analytical metho...